<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03544593</url>
  </required_header>
  <id_info>
    <org_study_id>11-01-2017</org_study_id>
    <nct_id>NCT03544593</nct_id>
  </id_info>
  <brief_title>The Volumetric Analysis of Fat Grafting</brief_title>
  <official_title>The Volumetric Analysis of Fat Grafting for Aesthetic Body Contouring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hunstad Kortesis Bharti Cosmetic Sugrery</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Allergan</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hunstad Kortesis Bharti Cosmetic Sugrery</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Title: The Volumetric Analysis of Fat Grafting for Aesthetic Body Contouring.

      Subjects who wish to undergo fat grafting for aesthetic body contouring will be offered
      enrollment to the study. The study will consist of a Screening/Baseline visit, Surgery day
      and 3 follow up visits. Each follow up visit will utilize Vectra 3D photography (Canfeild,
      NJ) to collect volumetric data. At the conclusion of the study, Volume data from Baseline and
      3 follow up visits will be analyzed to determine fat retention rates.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">January 4, 2018</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Graft retention</measure>
    <time_frame>9 months</time_frame>
    <description>Vectra 3D volumetric analysis will be utilized to evaluate graft retention.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Volume of adipose harvested (mL)</measure>
    <time_frame>Intra Op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of adipocyte injected (mL)</measure>
    <time_frame>Intra Op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operating room time (harvesting, processing, and reinjection time) (min)</measure>
    <time_frame>Intra Op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Standardized before and after photos</measure>
    <time_frame>Pre op, 3 months, 6 months, 9 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Autologous Fat Grafting</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Revolve System</intervention_name>
    <description>Fat grafting system</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Females or Males in good general health age 18 - 65 years of age

          2. Must be willing to give and sign a HIPAA form and informed consent form

          3. Must be willing and able to comply with all study protocols and schedules

          4. Negative urine pregnancy test prior to surgery treatment (if applicable)

          5. The patient must have had a stable weight (no fluctuation of &gt;15 pounds in a year),
             diet, and physical activity for the previous 6 months

        Exclusion Criteria:

          1. Pregnancy, currently breast feeding or planning pregnancy for the duration of the
             trial

          2. History of breast cancer if fat grafting to breasts

          3. Patients who smoke or use nicotine products

          4. Any UNCONTROLLED systemic disease -a potential patient in whom therapy for a systemic
             disease is not yet stabilized will not be considered for entry into the study

          5. Diabetes Mellitus

          6. Subject has a clinically significant coagulation disorder or disease, defined as a
             platelet count &lt; 100,000 per microliter or International Normalized Ratio &gt; 1.5 within
             4 weeks of surgery

          7. Patients under the age of 18

          8. Patients undergoing fat grafting but refuse enrollment

          9. Patients with an active infection

         10. Current participation or participation within 30 days prior to the start of this study
             in a drug or other investigational research study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kelly Costin, RN, BSN</last_name>
    <role>Study Director</role>
    <affiliation>Hunstad Kortesis Bharti Cosmetic Surgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kelly Costin, RN, BSN</last_name>
    <phone>7046599000</phone>
    <email>kelly.c@hkbsurgery.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kelly Costin</name>
      <address>
        <city>Huntersville</city>
        <state>North Carolina</state>
        <zip>28078</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Costin, RN, BSN</last_name>
      <phone>704-659-9000</phone>
      <email>kelly.c@hkbsurgery.com</email>
    </contact>
    <investigator>
      <last_name>Bill G Kortesis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joseph P Hunstad, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gaurav Bharti, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>May 8, 2018</study_first_submitted>
  <study_first_submitted_qc>May 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2018</study_first_posted>
  <last_update_submitted>May 21, 2018</last_update_submitted>
  <last_update_submitted_qc>May 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hunstad Kortesis Bharti Cosmetic Sugrery</investigator_affiliation>
    <investigator_full_name>Bill G Kortesis, MD</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

